# Cambiotics initiates first human clinical trial focused on PFAS reduction in firefighters with occupational PFAS exposure

- Source: PR Newswire M&A
- Published: 2026-11-03T15:47:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/cambiotics-initiates-first-human-clinical-trial-focused-on-pfas-reduction-in-firefighters-with-occupational-pfas-exposure-302928040.html
- Canonical: https://groundlevelnews.com/story/cambiotics-initiates-first-human-clinical-trial-focused-on-pfas-reduct-bfc9d0/

COPENHAGEN, Denmark, Nov. 3, 2026 /PRNewswire/ -- Cambiotics ApS ("Cambiotics"), the company developing beneficial bacteria designed to support the natural elimination of unwanted compounds, such as per- and polyfluoroalkyl substances (PFAS, known as "forever chemicals"), announced today...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._